Vertex Pharmaceuticals
VRTX
₹38,160
Share price
-1.68%
Change (1 day)
-3.17%
Change (1 year)
Categories
Market capitalization of Vertex Pharmaceuticals (VRTX)
Market cap: ₹9.799 Trillion
As of June 2025 Vertex Pharmaceuticals has a market cap of ₹9.799 Trillion. This makes Vertex Pharmaceuticals the world's 159th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Vertex Pharmaceuticals from 1996 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | ₹9.799 T | 8.51% |
| 2024 | ₹9.030 T | 3.46% |
| 2023 | ₹8.728 T | 42.3% |
| 2022 | ₹6.134 T | 47.46% |
| 2021 | ₹4.159 T | -7.45% |
| 2020 | ₹4.494 T | 11.15% |
| 2019 | ₹4.043 T | 36.77% |
| 2018 | ₹2.956 T | 22.18% |
| 2017 | ₹2.419 T | 94.89% |
| 2016 | ₹1.241 T | -39.71% |
| 2015 | ₹2.059 T | 13.15% |
| 2014 | ₹1.820 T | 69.62% |
| 2013 | ₹1.073 T | 115.28% |
| 2012 | ₹498.48 B | 36.05% |
| 2011 | ₹366.41 B | 14.69% |
| 2010 | ₹319.46 B | -19.64% |
| 2009 | ₹397.55 B | 92.37% |
| 2008 | ₹206.66 B | 70.6% |
| 2007 | ₹121.13 B | -42.05% |
| 2006 | ₹209.02 B | 55.22% |
| 2005 | ₹134.66 B | 264.25% |
| 2004 | ₹36.97 B | 0.55% |
| 2003 | ₹36.76 B | -36.65% |
| 2002 | ₹58.03 B | -34.83% |
| 2001 | ₹89.05 B | -55.23% |
| 2000 | ₹198.93 B | 409.02% |
| 1999 | ₹39.08 B | 21.83% |
| 1998 | ₹32.07 B | -1.91% |
| 1997 | ₹32.70 B | 7.13% |
| 1996 | ₹30.52 B |
End of Day market cap according to different sources
On Jun 20th, 2025 the market cap of Vertex Pharmaceuticals was reported to be:
₹9.799 Trillion
₹9.799 Trillion
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 Gilead Sciences GILD | ₹11.682 T | 19.21% | 🇺🇸 USA |
 AbbVie ABBV | ₹28.331 T | 189.11% | 🇺🇸 USA |
 Merck MRK | ₹17.183 T | 75.35% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | ₹8.254 T | -15.77% | 🇺🇸 USA |
 Johnson & Johnson JNJ | ₹31.195 T | 218.34% | 🇺🇸 USA |
 Enanta Pharmaceuticals
ENTA | ₹13.28 B | -99.86% | 🇺🇸 USA |